|
Reference
|
[ CR ] [ EČ ][ GS ]
|
Ahearn, G.S., Tapson, V.F., Rebeiz, A., Greenfield, J.C. (2002) Electrocardiography to Define Clinical Status in Primary Pulmonary Hypertension and Pulmonary Arterial Hypertension Secondary to Collagen Vascular Disease. Chest, 122(2): 524-527
|
[ CR ] [ EČ ][ GS ]
|
Bossone, E., Rubenfire, M., Bach, D.S., Ricciardi, M., Armstrong, W.F. (1999) Range of tricuspid regurgitation velocity at rest and during exercise in normal adult men: implications for the diagnosis of pulmonary hypertension. Journal of the American College of Cardiology, 33(6): 1662-1666
|
[ CR ] [ EČ ][ GS ]
|
Chemla, D., Herve, P. (2008) Estimation of mean pulmonary artery pressure: simpler than expected. Chest, 133(3): 592-593
|
[ EČ ][ GS ]
|
Condliffe, R., Kiely, D.G., Peacock, A.J., Corris, P.A., Gibbs, S.R., Vrapi, F., i dr. (2009) Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era. Am J Respir Crit Care Med, 179, str. 151-7
|
[ EČ ][ GS ]
|
Eisenberg, P.R., Lucore, C., Kaufman, L. (1999) Fibrinopeptide A levels indicative of pulmonary vascular thrombosis in patients with primary pulmonary hypertension. Circulation, 82, str. 84-7
|
[ CR ] [ EČ ][ GS ]
|
Eysmann, S.B., Palevsky, H.I., Reichek, N., Hackney, K., Douglas, P.S. (1989) Two-dimensional and Doppler-echocardiographic and cardiac catheterization correlates of survival in primary pulmonary hypertension. Circulation, 80(2): 353-360
|
[ CR ] [ EČ ][ GS ]
|
Farber, H.W., Simms, R.W., Lafyatis, R. (2010) Analytic Review: Care of Patients With Scleroderma in the Intensive Care Setting. Journal of Intensive Care Medicine, 25(5): 247-258
|
[ CR ] [ EČ ][ GS ]
|
Friedberg, M.K., Feinstein, J.A., Rosenthal, D.N. (2006) A Novel Echocardiographic Doppler Method for Estimation of Pulmonary Arterial Pressures. Journal of the American Society of Echocardiography, 19(5): 559-562
|
[ EČ ][ GS ]
|
Galiè, N., Manes, A., Uguccioni, L., Serafini, F., de Rosa, M., Branzi, A., i dr. (1998) Primary pulmonary hypertension: Insights into pathogenesis from epidemiology. Chest, 114(3 Suppl):184S-194S
|
[ EČ ][ 1 ][ GS ]
|
Galiè, N., Hoeper, M.M., Humbert, M., Torbicki, A., Vachiery, J.L., Barberaet, J.A., i dr. (2009) Guidelines for the diagnosis and treatment of pulmonary hypertension: The task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS),. Eur Heart J., 30(20), str. 2493-537
|
[ EČ ][ GS ]
|
Galiè, N., Ussia, G., Passarelli, P., Parlangeli, R., Branzi, A., Magnani, N. (1995) Role of pharmacologic tests in the treatment of primary pulmonary hypertension. Am J Cardiol, 75: 55A-62A
|
[ EČ ][ 1 ][ GS ]
|
Galiè, N., Manes, A., Negro, L., Palazzini, M., Bacchi-Reggiani, M.L., Branzi, A. (2009) A meta-analysis of randomized controlled trials in pulmonary arterial hypertension. Eur Heart J., 30(4), str. 394-403
|
[ CR ] [ EČ ][ GS ]
|
Hinderliter, A.L., Willis, I.P.W., Long, W., Clarke, W.R., Ralph, D., Caldwell, E.J., Williams, W., Ettinger, N.A., Hill, N.S., Summer, W.R. (1999) Frequency and prognostic significance of pericardial effusion in primary pulmonary hypertension. American Journal of Cardiology, 84(4): 481-484
|
[ CR ] [ EČ ][ GS ]
|
MacGregor, A.J., Canavan, R., Knight, C. (2001) Pulmonary hypertension in systemic sclerosis: risk factors for progression and consequences for survival. Rheumatology, 40(4): 453-459
|
[ CR ] [ PM ] [ EČ ][ 1 ][ GS ]
|
McLaughlin, V.V., Shillington, A. (2002) Survival in Primary Pulmonary Hypertension: The Impact of Epoprostenol Therapy. Circulation, 106(12): 1477-1482
|
[ CR ] [ EČ ][ GS ]
|
Mcquillan, B.M., Picard, M.H., Leavitt, M., Weyman, A.E. (2001) Clinical Correlates and Reference Intervals for Pulmonary Artery Systolic Pressure Among Echocardiographically Normal Subjects. Circulation, 104(23): 2797-2802
|
[ EČ ][ GS ]
|
Nauser, T.D., Stites, S.W. (2001) Diagnosis and treatment of pulmonary hypertension. Am Fam Physician, 63(9), str. 1789-98
|
[ EČ ][ 1 ][ GS ]
|
Rubin, L.J., Badesch, D.B. (2005) Evaluation and management of the patient with pulmonary arterial hypertension. Ann Intern Med, 143, str. 282-92
|
[ EČ ][ 1 ][ GS ]
|
Rudarakanchana, N., Trembath, R.C., Morrell, N.W. (2001) New insights into the pathogenesis and treatment of primary pulmonary hypertension. Thorax, 56, str. 888-90
|
[ CR ] [ EČ ][ 1 ][ GS ]
|
Runo, J.R., Loyd, J.E. (2003) Primary pulmonary hypertension. Lancet, 361(9368): 1533-1544
|
[ CR ] [ EČ ][ GS ]
|
Shapiro, S.M., Oudiz, R.J., Cao, T., Romano, M.A., Beckmann, X.J., Goegiou, D., i dr. (1997) Primary Pulmonary Hypertension: Improved Long-Term Effects and Survival With Continuous Intravenous Epoprostenol Infusion. Journal of the American College of Cardiology, 30(2): 343-349
|
|
|
|